Example: Heart Attack
Search clinical trials for: Intravenous ImmuneGlobulin
Total 1 results
-
NCT00306033Completed
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Pfizer
- Mid-Atlantic Nutrition Obesity Research Center
- BKK Mobil Oil
- Mayo Clinic
- M.D. Anderson Cancer Center
- Assistance Publique - Hôpitaux de Paris
- Cairo University
- Novartis Pharmaceuticals
- Hospital, Vannes
- Assiut University
- Universitätsklinikum Tulln
- Amphia Hospital
- Groupe Pasteur Mutualité
- AstraZeneca
- National Cancer Institute (NCI)
- Charlotte Gastroenterology and Hepatology
- First Hospital of Shijiazhuang City
- Beijing DMS Pharma Ltd.
- John Kempen
- GlaxoSmithKline
- View Full List
Medical Conditions
- Blood Flow Indexes
- Breast Cancer
- Depression
- Corpus Callosum Malformation
- Hematopoietic and Lymphoid Cell Neoplasm
- Asthma
- Pre-terminal Cancer
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Blood Coagulation Disorder Due to Liver Disease
- Infection Gastrointestinal
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Obesity
- Hypertension
- Prostate Cancer
- Leucocytosis
- Stroke
- Coronary Artery Disease
- Pain
- HIV Infections
- Nutritional Status in Hospitalised Geriatric Patients
- View Full List
Drug Interventions
- Triamcinolone Acetonide 4 mg intravitreal injection
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- Dexamethasone
- Carboplatin
- Cyclophosphamide
- docetaxel
- Gemcitabine
- Capecitabine
- CA-008
- Prednisone
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- Cisplatin
- 100 mg INX-08189 QD
- M4344 10 mg BIW
- Efficacy of Enbrel subcutaneously at Week 36
- Paclitaxel
- Dicofenac
- Iodixanol, Ioversol, Iopromide
- AC-150A 0.1%
- Bevacizumab
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Congo
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Denmark
- Contract Research Organizations in Georgia
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Qatar
- Contract Research Organizations in Romania
- Contract Research Organizations in United Arab Emirates
- CRO list by country